New system that defines Huntington's Disease will 'revolutionize' drug trials

A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by scientists; this 'significant' step paves the way for clinical trials of drugs in the earliest phase of disease.

from Top Health News -- ScienceDaily https://ift.tt/iEMu0Af